Evaluation of antitumor response to HDAC inhibitors in advanced head and neck cancer: A proportional meta-analysis of clinical trials
Journal of Oncology Pharmacy Practice
Published online on February 11, 2026
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
ObjectiveTo study the cumulative proportion of favorable response to Histone Deacetylase Inhibitor (HDACi) among head and neck cancer (HNC) patients.Data SourcesA systematic search (till 17th-May-2025) was carried out in PubMed, Scopus, and Web of Science ...
ObjectiveTo study the cumulative proportion of favorable response to Histone Deacetylase Inhibitor (HDACi) among head and neck cancer (HNC) patients.Data SourcesA systematic search (till 17th-May-2025) was carried out in PubMed, Scopus, and Web of Science ...